Representative Patents
| Patent No. |
Title |
| 7,309,600 |
Haemophilus influenzae sialyltransferase and methods of use thereof |
| 7,300,924 |
Anti-infective phosphonate analogs |
| 7,297,786 |
RNA interference in respiratory epitheial cells |
| 7,297,340 |
Vaccine and method for preventing biofilm formation |
| 7,279,338 |
Methods for determining cellular response to stimuli |
| 7,268,124 |
Geranylgeranyl pyrophosphate synthase inhibitors+ |
| 7,262,221 |
Amphiphilic star-like macromolecules for drug delivery |
| 7,261,901 |
Vaccine and compositions for the prevention and treatment of neisserial infections |
| 7,256,265 |
Streptococcal C5a peptidase vaccine |
| 7,250,172 |
Vaccine and compositions for the prevention and treatment of neisserial infections |
| 7,238,492 |
Method for predicting tumor recurrence |
| 7,232,829 |
Therapeutic compounds and methods |
| 7,232,808 |
Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
| 7,230,091 |
CCT protein expression promoter |
| 7,226,588 |
Non-toxic mutants of pathogenic gram-negative bacteria |
| 7,220,782 |
Methods to reduce the sensitivity of endothelially-compromised vascular smooth muscle |
| 7,189,554 |
Two-component system that controls bacterial membrane synthesis |
| 7,164,008 |
Isolated complexes of endotoxin and MD-2 |
| 7,160,727 |
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 7,153,661 |
Artificial antibody polypeptides |
| 7,150,970 |
Methods of inhibiting VEGF-C |
| 7,148,343 |
Compositions and methods for using a solid support to purify RNA |
| 7,139,602 |
Shape analysis of surfaces |
| 7,138,058 |
Acid stable membranes for nanofiltration |
| 7,135,575 |
P38 inhibitors and methods of use thereof |
| 7,135,339 |
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 7,129,049 |
Method of detecting equine glycogen storage disease IV |
| 7,122,615 |
Polyanhydrides with therapeutically useful degradation products |
| 7,119,171 |
Binding polypeptides |
| 7,115,719 |
Formulations and methods for denaturing proteins |
| 7,084,868 |
System and method for 3-D digital reconstruction of an oral cavity from a sequence of 2-D images |
| 7,078,490 |
Artificial antibody polypeptides |
| 7,049,315 |
Solubilized topoisomerase poisons |
| 7,005,129 |
Non-toxic mutants of pathogenic gram-negative bacteria |
| 6,995,154 |
Heterocyclic topoisomerase poisons |
| 6,992,089 |
Nitro and amino substituted topoisomerase agents |
| 6,992,088 |
Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
| 6,989,387 |
Nitro and amino substituted topoisomerase agents |
| 6,987,150 |
Modified sulfonamide polymers |
| 6,987,109 |
Solubilized topoisomerase poison agents |
| 6,964,964 |
Topoisomerase poison agents |
|
Our Services